会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Fluid separation devices, systems and methods
    • 流体分离装置,系统和方法
    • US08496606B2
    • 2013-07-30
    • US12866017
    • 2009-02-04
    • Edward F. LeonardIlan K. ReichStanley Cortell
    • Edward F. LeonardIlan K. ReichStanley Cortell
    • A61M1/14A61M1/16A61M1/34A61M1/36B01D61/24B01D61/58
    • A61M1/14A61M1/3482A61M2206/11
    • A membraneless separation device can be applied to a variety of treatments, such as the ultrafiltration of blood for a patient with end stage renal disease. An ultrafiltration device can include a membraneless separation device, which separates an incoming blood flow into a substantially cytoplasmic body-free plasma flow and remaining fraction, and a dialysate-free second stage, which selectively removes excess fluid, toxins and other substances from the plasma flow and returns the processed plasma to the membraneless separation device. A treatment protocol can include ultrafiltering blood of a patient using the ultrafiltration device and performing a secondary treatment on the blood of the patient at a reduced frequency compared to the ultrafiltering. The membraneless separation device can also be applied to treatment, analysis, and/or exchange of plasma from blood, or combined with conventional dialyzers to perform dialysis on a cytoplasmic body-free plasma fraction.
    • 无膜分离装置可用于各种治疗,例如用于终末期肾病的患者的血液超滤。 超滤装置可以包括无膜分离装置,其将进入的血流分离成基本上不含细胞质的无体质血浆流和剩余部分,以及无透析液的第二阶段,其从血浆中选择性地除去多余的流体,毒素和其他物质 流动并将处理的等离子体返回到无膜分离装置。 治疗方案可以包括使用超滤装置对患者的超滤血液,并且与超滤相比以更低的频率对患者的血液进行二次治疗。 无膜分离装置也可以应用于来自血液的血浆的治疗,分析和/或交换,或与常规透析器组合以在不含细胞质的体外血浆级分上进行透析。
    • 3. 发明申请
    • PORTABLE BLOOD FILTRATION DEVICES, SYSTEMS, AND METHODS
    • 便携式血液过滤装置,系统和方法
    • US20130102948A1
    • 2013-04-25
    • US13641559
    • 2011-03-24
    • Ilan K. ReichEdward F. LeonardFred Mermelstein
    • Ilan K. ReichEdward F. LeonardFred Mermelstein
    • A61M1/36
    • A61M1/3621A61M1/16A61M1/3472A61M1/3482A61M1/3486A61M2202/20A61M2202/203A61M2202/206A61M2205/8206
    • A blood filtration device, system, and method that can and selectively remove or reduce an unwanted, in certain cases unknown, substance from a patient's blood stream. More specifically, a specific size or size range of unwanted substance is selectively removed. The unwanted substance includes one or more of a pathogen, a toxin, an activated cell, and an administered drug. The device and system employ a microfluidic separation device that minimizes thrombogenesis and can permit the use of anticoagulants to be avoided. The device or system can be portable and can include its own power supply. Sensors in the system may monitor for the presence and/or concentration of unwanted species including pathogens or drugs and invoke a blood cleansing process responsively to the sensor signals in closed loop control process. The control may combine the infusion of therapeutic agents into the blood of a patient as well.
    • 血液过滤装置,系统和方法,其可以并且选择性地从患者的血液流中去除或减少在某些情况下不需要的物质。 更具体地,选择性地去除不需要的物质的具体尺寸或尺寸范围。 不想要的物质包括病原体,毒素,活化的细胞和给药的药物中的一种或多种。 该装置和系统采用使血栓形成最小化的微流体分离装置,并且可以允许避免使用抗凝剂。 该设备或系统可以是便携式的并且可以包括其自己的电源。 系统中的传感器可以监测不想要的物质(包括病原体或药物)的存在和/或浓度,并且在闭环控制过程中响应于传感器信号调节血液清洁过程。 该对照可以将治疗剂的输注组合到患者的血液中。
    • 5. 发明申请
    • FLUID SEPARATION DEVICES, SYSTEMS AND METHODS
    • 流体分离装置,系统和方法
    • US20110105982A1
    • 2011-05-05
    • US12866017
    • 2009-02-04
    • Edward F. LeonardIlan K. ReichStanley Cortell
    • Edward F. LeonardIlan K. ReichStanley Cortell
    • A61M5/00
    • A61M1/14A61M1/3482A61M2206/11
    • A membraneless separation device can be applied to a variety of treatments, such as the ultrafiltration of blood for a patient with end stage renal disease. An ultrafiltration device can include a membraneless separation device, which separates an incoming blood flow into a substantially cytoplasmic body-free plasma flow and remaining fraction, and a dialysate-free second stage, which selectively removes excess fluid, toxins and other substances from the plasma flow and returns the processed plasma to the membraneless separation device. A treatment protocol can include ultrafiltering blood of a patient using the ultrafiltration device and performing a secondary treatment on the blood of the patient at a reduced frequency compared to the ultrafiltering. The membraneless separation device can also be applied to treatment, analysis, and/or exchange of plasma from blood, or combined with conventional dialyzers to perform dialysis on a cytoplasmic body-free plasma fraction.
    • 无膜分离装置可用于各种治疗,例如用于终末期肾病的患者的血液超滤。 超滤装置可以包括无膜分离装置,其将进入的血流分离成基本上不含细胞质的无体质血浆流和剩余部分,以及无透析液的第二阶段,其从血浆中选择性地除去多余的流体,毒素和其他物质 流动并将处理的等离子体返回到无膜分离装置。 治疗方案可以包括使用超滤装置对患者的超滤血液,并且与超滤相比以更低的频率对患者的血液进行二次治疗。 无膜分离装置也可以应用于来自血液的血浆的治疗,分析和/或交换,或与常规透析器组合以在不含细胞质的体外血浆级分上进行透析。
    • 6. 发明申请
    • METHODS, APPARATUS, AND SYSTEMS FOR SEPARATING FLUIDS
    • 用于分离流体的方法,装置和系统
    • US20120103903A1
    • 2012-05-03
    • US13265201
    • 2010-04-19
    • Michael HillEdward F. Leonard
    • Michael HillEdward F. Leonard
    • B01D29/00
    • B01D61/147
    • A device for separating fluids includes a microfluidic channel with one or more wall filters or membranes through which portions of the flow in the microfluidic channel can be removed. The wall filters can have precisely defined pores therein which restrict the removal of certain particles while allowing other particles and/or fluids to freely flow therethrough. Because of the high and uniform pore density and low flow resistance of these filters, the pressure drop along the microfluidic channel may result in a negative trans-filter pressure, thereby causing reverse flow of extracted fluid back through the filter and into the microfluidic channel. Precise design of the microfluidic channel and control of flow characteristics can minimize and/or eliminate this reverse flow while allowing for sufficient sweeping of the filter surface to inhibit clogging with particles.
    • 用于分离流体的装置包括具有一个或多个壁过滤器或膜的微流体通道,通过该流体可以去除微流体通道中的流动的部分。 壁过滤器可以在其中具有精确定义的孔,其限制某些颗粒的去除,同时允许其它颗粒和/或流体自由地流过其中。 由于这些过滤器具有高且均匀的孔密度和低流动阻力,沿着微流体通道的压力降可能导致负的反式过滤器压力,从而导致提取的流体反向流过过滤器并进入微流体通道。 微流体通道的精确设计和流动特性的控制可以最大限度地减少和/或消除这种反向流动,同时允许过滤表面的充分清扫以抑制颗粒堵塞。
    • 9. 发明申请
    • APPARATUS AND SYSTEMS FOR MEMBRANELESS SEPARATION OF FLUIDS
    • 用于液体无菌分离的装置和系统
    • US20100004578A1
    • 2010-01-07
    • US12499038
    • 2009-07-07
    • Edward F. LeonardAlan C. WestNina C. ShapleyZhongliang Tang
    • Edward F. LeonardAlan C. WestNina C. ShapleyZhongliang Tang
    • A61M1/14
    • A61M1/14A61M2206/11B01D11/0288B01D11/0492B01D11/0496B01L3/5027
    • The present invention is directed to devices, systems and methods for removing undesirable materials from a sample fluid by contact with a second fluid. The sample fluid flows as a thin layer adjacent to, or between, concurrently flowing layers of the second fluid, without an intervening membrane. In various embodiments, a secondary separator is used to restrict the removal of desirable substances and effect the removal of undesirable substances from blood. The invention is useful in a variety of situations where a sample fluid is to be purified via a diffusion mechanism against an extractor fluid. Moreover, the invention may be used for the removal of components from a sample fluid that vary in size. When blood is the sample fluid, for example, this may include the removal of small molecules, middle molecules, macromolecules, macromolecular aggregates, and cells, from the blood sample to the extractor fluid.
    • 本发明涉及通过与第二流体接触从样品流体中除去不需要的材料的装置,系统和方法。 样品流体作为与第二流体的同时流动的层相邻或相邻的薄层流动,而没有中间膜。 在各种实施方案中,使用次级分离器来限制所需物质的去除并且实现从血液中除去不需要的物质。 本发明可用于各种情况,其中样品液体经由针对抽提流体的扩散机制进行纯化。 此外,本发明可用于从尺寸变化的样品流体中除去组分。 例如,当血液是样品液体时,这可能包括从血液样品到提取液中去除小分子,中分子,大分子,大分子聚集体和细胞。